Access Compliance DEA Events 
Cannabis Law Report
JUNE 11, 2021
Cannabis faces an overall lack of access to financial institutions as well as IRC 280E, and ketamine certainly does not. When people hear of ketamine clinics, they tend to think they’re dealing with an emerging psychedelic medicine in the health and wellness market. Although many are still self-pay mainly for two reasons: 1.
Dykema (Cannabis Law Blog)
SEPTEMBER 20, 2021
Marihuana Event Organizer. Marihuana Safety Compliance Facility. Temporary Marihuana Event. Event organizers would need to provide proof of coverage for all vendors at an event. Temporary marihuana event license; application; operations. Excess Marihuana Grower. Marihuana Microbusiness. Marihuana Processor.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Canna Law Blog
OCTOBER 29, 2019
Plans must also ensure that samples are representative of an entire hemp lot and the state or tribal agency charged with testing must have unrestricted access to all land, building, and structures used for the cultivation, handling, and storage of hemp. Labs that test cannabis for THC levels must be registered with the DEA.
CannaMD
SEPTEMBER 15, 2020
MORE DETAILS: On June 16, 2014, Florida became the 22nd state to legalize (at least partial) access to medical marijuana when Governor Rick Scott signed the Compassionate Medical Cannabis Act of 2014. Once you begin medical marijuana treatment, the only people that will have access to your records will be: Your doctor. Law enforcement.
Cannabis Law Report
JUNE 1, 2021
A replay will be accessible by webcast until 11:59 PM ET on August 30, 2021 at: [link]. Drug Enforcement Administration (the “DEA”), the U.S. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements.
Cannabis Law Report
SEPTEMBER 23, 2019
Surveying marijuana use is essential to gauge public health implications of increased access to marijuana, cannabinoid, and cannabis products. Due to the Schedule I classification by the Drug Enforcement Agency (DEA), researchers seeking to investigate health effects associated with cannabis must follow a regimented application process.
Meadow
JULY 13, 2018
One of our primary goals for Meadowlands was to open the channels of communication and make sure compliance and regulatory information are available to everyone in the community who needs it, not just those who can afford compliance experts. We believe in lowering the cost of compliance through free-flowing and accurate information.
Expert insights. Personalized for you.
104 
Let's personalize your content